IQVIA Holdings Inc. Profile Avatar - Palmy Investing

IQVIA Holdings Inc.

IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solution…
Medical - Diagnostics & Research
US, Durham [HQ]

Ratios

14 Sheets · Starting from 2023
Margins, Growth Rates In %
Ratio 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Profitability
Gross Margin
28.52 26.39 25.34 26.22 27.14 27.90 30.94 35.30 35.21 34.16 33.97 33.45 34.89 27.56
Profit Margin
4.09 5.59 3.65 4.44 6.53 6.75 1.67 13.44 2.49 1.72 2.46 6.96 7.57 9.05
Operating Margin
10.07 7.98 8.15 9.07 10.81 11.27 9.33 7.38 7.12 7.01 6.44 10.04 12.48 13.88
EPS Growth
- - 50.78 -26.43 28.87 51.91 13.31 -75.56 680.52 -78.87 -22.84 48.98 245.89 15.25 26.98
Return on Assets (ROA)
- - 10.41 7.10 7.39 10.78 9.86 0.54 5.76 1.15 0.82 1.14 3.91 4.31 5.09
Return on Equity (ROE)
- - -24.92 -13.06 -33.95 -50.62 -115.35 1.33 16.14 3.86 3.18 4.65 15.99 18.92 22.22
Return on Invested Capital (ROIC)
- - 31.65 24.29 23.58 26.05 21.38 1.13 15.62 3.43 2.89 3.12 6.45 7.75 9.74
Solvency
Equity Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt/Assets
- - 84.89 96.91 66.72 69.37 62.85 33.95 44.96 48.81 51.79 52.53 50.38 51.35 51.65
Debt/Equity
- - -203.20 -178.15 -306.56 -325.75 -735.16 83.40 126.09 163.94 200.58 215.03 205.86 225.69 225.46
Debt/EBITDA
- - 312.00 356.52 215.61 194.60 184.14 531.62 511.93 517.97 533.52 517.98 393.60 401.60 400.84
Debt/Capitalization
- - 196.90 227.96 148.41 144.30 115.74 45.47 55.77 62.11 66.73 68.26 67.31 69.30 69.27
Interest Debt per Share USD
- - 16.59 20.37 17.48 18.70 20.88 49.26 48.54 56.07 64.01 69.63 66.94 71.57 78.88
Debt Growth
- - - - 22.83 -15.52 12.09 7.61 191.76 42.01 7.65 9.39 7.17 -3.61 4.61 9.38
Liquidity
Current Ratio
- - 114.54 114.57 131.27 145.80 151.30 123.36 118.80 109.62 104.59 111.67 90.88 89.30 86.21
Quick Ratio
- - 101.56 98.24 113.22 125.92 134.49 110.13 104.86 96.24 89.66 95.83 77.96 76.53 75.63
Cash Ratio
- - 43.31 43.08 52.50 58.93 61.30 44.29 33.02 25.21 21.22 39.80 26.06 21.80 21.20
Operating Cash Flow Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - -
Turnover
Inventory Turnover
- - 3,931.42 3,452.57 2,733.91 2,396.20 2,684.83 3,861.79 4,315.75 4,467.55 5,289.86 4,716.98 5,918.59 6,213.25 - -
Receivables Turnover
- - 604.02 637.71 542.29 534.97 478.20 395.06 477.40 422.74 420.32 460.62 531.78 486.82 439.64
Payables Turnover
- - 4,549.31 4,288.16 3,739.60 3,658.43 2,843.47 1,900.00 1,956.83 1,543.71 290.61 266.62 309.73 282.93 1,533.15
Asset Turnover
- - 186.31 194.69 166.28 165.16 146.13 32.43 42.82 46.17 47.69 46.24 56.20 56.87 56.24
Coverage
Interest Coverage
279.29 316.56 295.03 374.33 586.93 635.23 445.83 207.80 178.99 173.83 175.72 371.47 432.45 289.57
Asset Coverage
- - - - - - - - - - - - 100 100 100 100 100 100 100 100
Cash Flow Coverage (CFGR)
- - 8.16 13.86 19.42 18.83 19.28 11.94 9.49 11.39 11.77 15.18 23.65 17.37 15.60
EBITDA Coverage
300 400 300 400 700 700 700 500 400 400 500 700 700 400
Dividend Coverage
-200 - - - - - - - - - - - - - - - - - - - - - - - - - -
Time Interest Earned (TIE)
100 100 100 100 100 100 100 100 100 100 100 100 100 200
Market Prospects
Dividend Yield
1.28 5.46 10.75 - - - - - - - - - - - - - - - - - - - - - -
Earnings Yield
3.04 4.58 3.36 3.94 4.73 4.58 1.01 6.14 1.09 0.63 0.81 1.79 2.84 3.19
Price/Earnings (P/E)
3,289.91 2,185.31 2,975.82 2,538.92 2,114.30 2,181.74 9,860.05 1,628.92 9,136.61 15,782.67 12,285.03 5,590.23 3,523.13 3,131.64
Price/Book (P/B)
- - -544.47 -388.63 -861.98 -1,070.30 -2,516.61 131.35 262.95 352.46 502.16 571.16 893.77 666.74 695.81
Price/Sales (P/S)
134.64 122.08 108.59 112.81 138.00 147.24 164.86 218.94 227.27 271.87 301.75 389.23 266.74 283.42
Price/Cash Flow (P/CF)
1,397.15 3,282.61 1,573.86 1,447.76 1,745.21 1,775.90 1,318.49 2,198.21 1,887.07 2,127.37 1,749.63 1,835.54 1,700.77 1,978.95
End of IQV's Analysis
CIK: 1478242 CUSIP: 46266C105 ISIN: US46266C1053 LEI: - UEI: -
Secondary Listings